Induction of Apoptosis and Down-Regulation of Bcl-XL in Cancer Cells by a Novel Small Molecule, 2[ [3-(2,3-Dichlorophenoxy)propyl]amino]ethanol
- 1 February 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (3) , 1110-1113
- https://doi.org/10.1158/0008-5472.can-03-2790
Abstract
In a search for new anticancer agents, we identified that 2[[3-(2,3-dichlorophenoxy) propyl]amino]ethanol (2,3-DCPE) induced apoptosis more effectively in various cancer cells than in normal human fibroblasts. We further evaluated the cell-killing effects of this compound in vitro in several human cancer cell lines and normal human fibroblasts. A cell viability assay showed that IC50s for human colon cancer cell lines LoVo and DLD-1, for human lung cancer cell lines H1299 and A549, and for normal human fibroblasts were 0.89, 1.95, 2.24, 2.69, and 12.6 μm, respectively. Subsequent studies revealed that 2,3-DCPE could cause cleavage of caspase-8, caspase-3, caspase-9, and poly(ADP-ribose) polymerase and release of cytochrome c in cancer cells but not in normal human fibroblasts. Our data also showed that 2,3-DCPE attenuated the protein level of Bcl-XL and that apoptosis induction by 2,3-DCPE could be blocked by enforced overexpression of Bcl-XL. Our results suggest that 2,3-DCPE might be a potential new anticancer agent.Keywords
This publication has 10 references indexed in Scilit:
- Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell lineGene Therapy, 2002
- Role of BAX in the Apoptotic Response to Anticancer AgentsScience, 2000
- Bcl-xL Prevents the Initial Decrease in Mitochondrial Membrane Potential and Subsequent Reactive Oxygen Species Production during Tumor Necrosis Factor Alpha-Induced ApoptosisMolecular and Cellular Biology, 2000
- Mechanism-Based Target Identification and Drug Discovery in Cancer ResearchScience, 2000
- High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compoundsCurrent Opinion in Chemical Biology, 1998
- Bcl-xL Regulates the Membrane Potential and Volume Homeostasis of MitochondriaPublished by Elsevier ,1997
- Role for Bcl-xLas an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosisProceedings of the National Academy of Sciences, 1997
- Expression of bcl-xL can confer a multidrug resistance phenotypeBlood, 1995
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).British Journal of Clinical Pharmacology, 1988